Strategic alliance for clinical research announced

Article

Research Dynamics Consulting Group and ClinROC LLC have announced a strategic alliance to provide clinical research and product development services for the ophthalmic industry.

Research Dynamics Consulting Group and ClinROC LLC have announced a strategic alliance to provide clinical research and product development services for the ophthalmic industry.

ClinROC LLC will collaborate with Research Dynamics Consulting Group to offer clinical knowledge and experience in ophthalmology. The move will see cost-efficient conduct and management of clinical research trials for the ophthalmic, biologic and medical device industries.

Lorraine D. Ellis, CEO of the Research Consulting Group, commented, "Working with ClinROC provides our clients with our operational efficiency and ophthalmology trial experience together with ClinROC’s extensive medical and clinical expertise.” The strategic partnership with Research Dynamics Consulting Group is the latest exciting development for ClinROC, LLC and concentrates on meeting the development needs of ophthalmic medical devices, pharmaceuticals and diagnostics."

Dr Tara Vaz, Clinical Affairs and Co-Founder of ClinROC LLC, added, "This alliance allows our companies to conduct various designs and sizes of clinical trials to the highest quality standards, while providing the medical, clinical and scientific oversight to ensure the robustness of the outcomes."

Newsletter

Join ophthalmologists across Europe—sign up for exclusive updates and innovations in surgical techniques and clinical care.

Recent Videos
A photo of Seville, Spain, with the Congress on Controversies in Ophthalmology logo superimposed on it. Image credit: ©francovolpato – stock.adobe.com; logo courtesy COPHy
Anat Loewenstein, MD, Professor and Director, Department of Ophthalmology, Tel Aviv Medical Center, discusses the Congress on Controversies in Ophthalmology (COPHy)
Anat Loewenstein, MD, speaks about the 22nd Annual Angiogenesis, Exudation, and Degeneration Meeting in February 2025 and shares her global forecast for AI-driven home OCT
Sarah M. Thomasy, DVM, PhD, DACVO, a veterinary ophthalmologist at UC Davis, talks about how her research at the Glaucoma 360 symposium
I. Paul Singh, MD, an anterior segment and glaucoma specialist, discusses the Glaucoma 360 conference, where he participated in a panel discussion on the use of artificial intelligence (AI) in glaucoma care.
Charles Wykoff, MD, PhD, discusses his Floretina ICOOR presentation topic, retinal non-perfusion in diabetic retinopathy, with David Hutton, editor of Ophthalmology Times
Elizabeth Cohen, MD, discusses the Zoster Eye Disease study at the 2024 AAO meeting
Victoria L Tseng, MD, PhD, professor of ophthalmology and glaucoma specialist, UCLA
© 2025 MJH Life Sciences

All rights reserved.